Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

Todd Neale

August 08, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2024

Shelley Wood

February 01, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Opinion Off Script

My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration

Benoy Shah, MBBS, MD(Res)

January 24, 2024

Advertisement

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

ACC/AHA Update Performance, Quality Measures for HF Care

August 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for May 2024

FDA Approves TriClip TEER Device for Tricuspid Repair

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Debating the Role of T-TEER in the Sickest Patients

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

TCTMD’s Top 10 Most Popular Stories for January 2024

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content